[1]
Ismaila, A., Walker, A., Sayani, A., Laroche, B., Nickel, J.C., Posnett, J. and Su, Z. 2013. Cost-effectiveness of dutasteride-tamsulosin combination therapy for the treatment of symptomatic benign prostatic hyperplasia: A Canadian model based on the CombAT trial. Canadian Urological Association Journal. 7, 5-6 (Jun. 2013), e393–401. DOI:https://doi.org/10.5489/cuaj.1380.